C3.ai (AI) was downgraded to Perform from Outperform by Oppenheimer due to weaker-than-expected preliminary results for the ...

Investors resolve the dissonance by telling themselves they will know when the bubble is about to burst and get out in time. But the history of bubbles teaches us that this belief represents a triumph ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...

Oppenheimer said the results point to possible long-term weakness in demand, prompting it to cut its full-year revenue forecast by more than a third and to scale back 2027 expectations to match the ...

Northland Securities analyst Michael Latimore downgraded C3.ai (AI) stock to a “Hold” rating from “Buy” after the company’s preliminary Q1FY26 results missed its own guidance. Latimore also slashed ...

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), headquartered in Massachusetts, is a global biopharmaceutical enterprise ...

Tom Siebel, c3.ai CEO, joins 'Closing Bell Overtime' to talk quarterly results, recent stock performance, restructuring sales ...

BigBear's sales trajectory is concerning, and its losses are growing. The company has a non-negligible amount of debt already and negative cash flows. Despite this, the stock still carries a hefty ...

A number of stocks jumped in the afternoon session after cooler-than-expected inflation data ignited investor optimism for a ...

BigBear.ai (BBAI) shares plummeted more than 20% during market action on Tuesday, following second quarter results that ...